These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Recombinant Salmonella vectors in vaccine development.
    Author: Curtiss R, Kelly SM, Tinge SA, Tacket CO, Levine MM, Srinivasan J, Koopman M.
    Journal: Dev Biol Stand; 1994; 82():23-33. PubMed ID: 7958478.
    Abstract:
    A diversity of means are available for the attenuation of Salmonella which can be used to immunize animals and humans orally to elicit mucosal, humoral and cellular immune responses. Avirulent Salmonellae can be genetically engineered to express foreign antigens and the recombinant avirulent Salmonellae are capable of stable, high-level expression of the foreign antigen in the orally immunized animal or human host. The resulting vaccines are safe, efficacious, and are easy and economical to use.
    [Abstract] [Full Text] [Related] [New Search]